In vitro susceptibilities of Mycoplasma hominis to six fluoroquinolones as determined by E test
- PMID: 10508049
- PMCID: PMC89525
- DOI: 10.1128/AAC.43.10.2571
In vitro susceptibilities of Mycoplasma hominis to six fluoroquinolones as determined by E test
Abstract
Twenty isolates of Mycoplasma hominis were tested for their susceptibility to six fluoroquinolones by the E test. The MICs at which 90% of the isolates were inhibited (in micrograms per milliliter) were as follows: sparfloxacin, 0.031; clinafloxacin, moxifloxacin, and trovafloxacin, 0.063; levofloxacin, 0.25; and ciprofloxacin, 0.5. Increasing the amount of inoculum or incubation in CO(2) elevated MICs by </=1 dilution. E tests produce fluoroquinolone MICs comparable to those obtained by agar and microbroth dilution for M. hominis.
Similar articles
-
Fluoroquinolone resistance in Bacteroides fragilis following sparfloxacin exposure.Antimicrob Agents Chemother. 1999 Sep;43(9):2251-5. doi: 10.1128/AAC.43.9.2251. Antimicrob Agents Chemother. 1999. PMID: 10471574 Free PMC article.
-
In vitro comparison of agar and microbroth dilution methods for determination of MICs for Mycoplasma hominis.J Microbiol Methods. 2005 Feb;60(2):285-8. doi: 10.1016/j.mimet.2004.10.007. J Microbiol Methods. 2005. PMID: 15590104
-
In-vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum to clinafloxacin, PD 131628, ciprofloxacin and comparator drugs.J Antimicrob Chemother. 1997 Aug;40(2):308-9. doi: 10.1093/jac/40.2.308. J Antimicrob Chemother. 1997. PMID: 9302005 No abstract available.
-
In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391.Antimicrob Agents Chemother. 1991 Jun;35(6):1181-5. doi: 10.1128/AAC.35.6.1181. Antimicrob Agents Chemother. 1991. PMID: 1929260 Free PMC article.
-
Comparative in-vitro activity of levofloxacin, other fluoroquinolones, doxycycline and erythromycin against Ureaplasma urealyticum and Mycoplasma hominis.J Antimicrob Chemother. 1999 Jun;43 Suppl C:33-6. doi: 10.1093/jac/43.suppl_3.33. J Antimicrob Chemother. 1999. PMID: 10404335
Cited by
-
Mycoplasma hominis, a Rare but True Cause of Infective Endocarditis.J Clin Microbiol. 2015 Sep;53(9):3068-71. doi: 10.1128/JCM.00827-15. Epub 2015 Jul 1. J Clin Microbiol. 2015. PMID: 26135868 Free PMC article. Review.
-
Integrating the Human and Animal Sides of Mycoplasmas Resistance to Antimicrobials.Antibiotics (Basel). 2021 Oct 7;10(10):1216. doi: 10.3390/antibiotics10101216. Antibiotics (Basel). 2021. PMID: 34680797 Free PMC article. Review.
-
In vitro susceptibilities to and bactericidal activities of garenoxacin (BMS-284756) and other antimicrobial agents against human mycoplasmas and ureaplasmas.Antimicrob Agents Chemother. 2003 Jan;47(1):161-5. doi: 10.1128/AAC.47.1.161-165.2003. Antimicrob Agents Chemother. 2003. PMID: 12499185 Free PMC article.
-
Mycoplasma hominis necrotizing pleuropneumonia in a previously healthy adolescent.BMC Infect Dis. 2010 Nov 24;10:335. doi: 10.1186/1471-2334-10-335. BMC Infect Dis. 2010. PMID: 21106079 Free PMC article.
-
Comparative in vitro susceptibilities and bactericidal activities of investigational fluoroquinolone ABT-492 and other antimicrobial agents against human mycoplasmas and ureaplasmas.Antimicrob Agents Chemother. 2003 Dec;47(12):3973-5. doi: 10.1128/AAC.47.12.3973-3975.2003. Antimicrob Agents Chemother. 2003. PMID: 14638513 Free PMC article.
References
-
- Cohen M A, Huband M D. In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum to clinafloxacin, PD 131628, ciprofloxacin and comparator drugs. J Antimicrob Chemother. 1997;40:308–309. - PubMed
-
- Jones R N. Highlights from two international symposia on the subject of the expanded role of the Etest. Diagn Microbiol Infect Dis. 1994;19:149. . (Foreword.)
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources